National Institutes of Health (NIH) Awards Phase II Grant Monies of $1.66 MM to TechniScan Medical Systems

SALT LAKE CITY--(BUSINESS WIRE)--TechniScan Medical Systems (TMS), Inc., a Salt Lake City-based developer of ultrasound technology for breast imaging, today announced a continuation of its $2.8 million Small Business Innovation Research (SBIR) funding from the National Cancer Institute (NCI)/National Institutes of Health (NIH). Phase II monies for the 12 months beginning April 2007 through March 2008 have been awarded in the amount of $1.66 million.

Back to news